PB2207: NEUTROPHIL–TO-LYMPHOCYTE RATIO IS AN EARLY SCREENING TOOL FOR DIAGNOSIS OF POLYCYTHEMIA VERA

Bibliographic Details
Published in:	HemaSphere
Main Authors:	Seug Yun Yoon, Min-Young Lee, Kyoung Ha Kim, Namsu Lee, Jong-Ho Won
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975580.74344.c2

Similar Items

Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera
by: Tiziano Barbui, et al.
Published: (2025-08-01)

Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis
by: Tiziano Barbui, et al.
Published: (2024-11-01)

PB2245: POLYCYTHEMIA VERA (PV) AND SECONDARY POLYCYTHEMIA (SP): ARE METABOLIC DIFFERENCES JUST THEORIES?
by: Osman Yokus, et al.
Published: (2023-08-01)

PB2202: NOVEL PREDICTORS FOR VENOUS AND ARTERIAL THROMBOSIS IN POLYCYTHEMIA VERA
by: Jelena Ivanović, et al.
Published: (2023-08-01)

PB2190: COMORBIDITIES PREDICT WORSE PROGNOSIS IN PATIENTS WITH POLYCYTHEMIA VERA
by: Isidora Arsenović, et al.
Published: (2023-08-01)

PB2207: IN VITRO VALIDATION OF DENDRIMER-BASED APPROACH FOR MICRO-RNA DELIVERY INTO LEUKEMIA CELLS
by: N. Knauer, et al.
Published: (2022-06-01)

PB2244: FEATURES OF POLYCYTHEMIA VERA WITH THE JAK 2 EXON 12 MUTATION.
by: Irina Soubortseva, et al.
Published: (2023-08-01)

OCT angiography in polycythemia vera
by: Pradeep K Panigrahi
Published: (2025-06-01)

Polycythemia vera and dengue fever
by: Prasad R Koduri
Published: (2020-01-01)

PB2251: TWO POLYCYTHEMIA VERA PATIENTS WITH A DIAGNOSIS OF CONCOMITANT HEREDITARY HEMOCHROMATOSIS
by: H. D. Kiper Unal, et al.
Published: (2022-06-01)

PB2045: POLYCYTHEMIA VERA IN YOUNG SUBJECTS: ABOUT A COHORT OF 11 CASES
by: S. Bougherira, et al.
Published: (2022-06-01)

P1036: VOLUMETRIC SPLENOMEGALY IN PATIENTS WITH POLYCYTHEMIA VERA
by: M.-W. Lee, et al.
Published: (2022-06-01)

Coexistence of chronic lymphocytic leukemia and polycythemia vera: a case report and review of the literature
by: Serdal Korkmaz, et al.
Published: (2016-09-01)

Treatment progress of phlebotomy for polycythemia vera
by: YANG Yanjie, et al.
Published: (2025-08-01)

Polycythemia Vera and associated risk factors
by: Ben Salem Sirine, et al.
Published: (2023-01-01)

How we treat polycythemia vera
by: V. A. Shuvaev, et al.
Published: (2024-01-01)

Takotsubo Cardiomyopathy Associated with Polycythemia Vera
by: Sijan Basnet, et al.
Published: (2018-01-01)

When hemolysis masks polycythemia vera
by: Coralie Derrieux, et al.
Published: (2019-03-01)

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials
by: Tiziano Barbui, et al.
Published: (2017-06-01)

Rare Case of Concomitant Polycythemia Vera and Chronic Lymphocytic Leukemia in a Young Male Patient
by: Ting Li, et al.
Published: (2023-03-01)

CHALLENGES IN INTERPRETING AVWS SCREENING IN POLYCYTHEMIA VERA: CORRELATIONS WITH CLINICAL AND LABORATORY FEATURES
by: V Weihermann, et al.
Published: (2024-10-01)

<it>CD177</it>: A member of the <it>Ly-6 </it>gene superfamily involved with neutrophil proliferation and polycythemia vera
by: Bettinotti Maria, et al.
Published: (2004-03-01)

Dermatomyositis Associated with Myelofibrosis following Polycythemia Vera
by: Naomi Fei, et al.
Published: (2017-01-01)

Schizophrenia and Polycythemia Vera: A Case Report
by: N. El Moussaoui, et al.
Published: (2024-04-01)

P1016: POLYCYTHEMIA VERA AND IMMUNE THROMBOGENESIS
by: R. Cacciola, et al.
Published: (2022-06-01)

Polycythemia vera and management of the thrombotic risk: an update
by: Massimo Franchini
Published: (2023-12-01)

Aberrant expression of microRNA in polycythemia vera
by: Hana Bruchova, et al.
Published: (2008-07-01)

Prevention of thrombosis in polycythemia vera and essential thrombocythemia
by: Raffaele Landolfi, et al.
Published: (2008-03-01)

Polycythemia Vera: Barriers to and Strategies for Optimal Management
by: Duminuco A, et al.
Published: (2023-12-01)

P1042: COMPARISON OF THE RESPONSE TO ROPEGINTERFERON ALFA-2B IN HYDROXYUREA NAÏVE VERSUS RESISTANCE/INTOLERANCE POLYCYTHEMIA VERA: THE KOREAN SINGLE-ARM, OPEN-LABEL MULTICENTER STUDY
by: Sung-Eun Lee, et al.
Published: (2023-08-01)

PB2201: ASSOCIATION OF HIGH PLATELETCRIT WITH THROMBOTIC RISK IN POLYCYTHEMIA VERA DEPENDS ON HEMATOCRIT AND LEUKOCYTE COUNT
by: Ivan Krecak, et al.
Published: (2023-08-01)

Determining level of endogenous serum erythropoietin for differential diagnosis of polycythemia vera and symptomatic polycythemia
by: Kostyukevych O.M.
Published: (2013-06-01)

About hematopoietic properties of peripheral blood lymphocytes RNA from patients with polycythemia vera and healthy donors
by: A. G. Babaeva, et al.
Published: (2015-06-01)

Identifying Patients with Polycythemia Vera at Risk of Thrombosis after Hydroxyurea Initiation: The Polycythemia Vera—Advanced Integrated Models (PV-AIM) Project
by: Srdan Verstovsek, et al.
Published: (2023-07-01)

Size and Shape of Jupiter Trojan (2207) Antenor from Stellar Occultations
by: F. S. Ferreira, et al.
Published: (2025-01-01)

PB2195: CHARACTERISTICS OF PATIENTS WITH POLYCYTHEMIA VERA: RESULTS FROM A US ELECTRONIC HEALTH RECORDS DATABASE.
by: Ronald Hoffman, et al.
Published: (2023-08-01)

Polycythemia Vera: New Diagnostic Concept and Its Types
by: AM Kovrigina, et al.
Published: (2016-04-01)

Polycythemia Vera in Pregnancy: A Descriptive Review of the Literature
by: Nicole Xu, et al.
Published: (2023-04-01)

Toxic encephalopathy in a clinicl case of polycythemia vera
by: P. I. Kuznetsova, et al.
Published: (2020-01-01)

Evaluation of the Benefit of Ropeginterferon Treatment in Patients with Polycythemia Vera
by: Diana GRASU, et al.
Published: (2025-03-01)